# Mistletoe (Viscum album)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/mistletoe
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** European
**Also Known As:** Viscum album, European mistletoe, White mistletoe, Birdlime, All-heal, Golden bough, Herbe de la croix, Mistel

## Overview

Mistletoe (Viscum album) contains bioactive viscotoxins and lectins that modulate immune cell activity and demonstrate cytotoxic effects against cancer cells. The herb's phenolic compounds provide [antioxidant activity](/ingredients/condition/antioxidant) by scavenging free radicals and inhibiting lipid peroxidation.

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant) through phenolic compounds and flavonoids that scavenge free radicals and inhibit lipid peroxidation (evidence quality: in vitro studies only)
• Immune system modulation via viscotoxins and viscolectins that may stimulate natural killer cells (evidence quality: preliminary mechanistic studies)
• High amino acid content (63-87 mg/mL) providing potential nutritional support (evidence quality: compositional analysis only)
• Contains quercetin, rutin, and catechins with documented antioxidant properties (evidence quality: phytochemical characterization)
• Polysaccharide and polypeptide fractions that may contribute to [immunomodulatory](/ingredients/condition/immune-support) effects (evidence quality: theoretical based on composition)

## Mechanism of Action

Viscotoxins and viscolectins in mistletoe bind to cell membrane receptors and stimulate natural killer cell activity while inducing apoptosis in abnormal cells. The phenolic compounds and flavonoids neutralize [reactive oxygen species](/ingredients/condition/antioxidant) through electron donation and chelate metal ions that catalyze oxidative reactions. Mistletoe lectins specifically target galactose residues on cell surfaces, triggering immune responses and [cytokine](/ingredients/condition/inflammation) production.

## Clinical Summary

Current evidence for mistletoe comes primarily from in vitro studies and small preliminary clinical trials with limited sample sizes. Some European studies have examined mistletoe extracts as adjuvant cancer therapy, showing potential improvements in quality of life measures, though large-scale randomized controlled trials are lacking. The [antioxidant](/ingredients/condition/antioxidant) effects have been demonstrated in laboratory settings but require human clinical validation. Most research focuses on injectable pharmaceutical preparations rather than oral supplements.

## Nutritional Profile

{"macronutrients": {"protein": "High amino acid content (63-87 mg/mL)"}, "micronutrients": {"vitamins": "Not specifically quantified", "minerals": "Not specifically quantified"}, "bioactive_compounds": {"phenolic_compounds": "Present, specific concentration not quantified", "flavonoids": "Present, specific concentration not quantified", "viscotoxins": "Present, specific concentration not quantified", "viscolectins": "Present, specific concentration not quantified"}, "bioavailability_notes": "Bioactive compounds have demonstrated [antioxidant](/ingredients/condition/antioxidant) and immune-modulating activities primarily in vitro; bioavailability in humans not well-established."}

## Dosage & Preparation

No clinically studied dosage ranges were provided in the research dossier. The available data only describes the chemical composition of mother tinctures without establishing therapeutic dosing recommendations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Raw mistletoe plant is toxic and can cause severe gastrointestinal symptoms, [cardiovascular](/ingredients/condition/heart-health) effects, and potentially fatal poisoning. Standardized extracts may cause injection site reactions, fever, and flu-like symptoms when administered therapeutically. Mistletoe may interact with immunosuppressive medications and could theoretically interfere with chemotherapy drugs. Pregnant and breastfeeding women should avoid mistletoe due to potential uterine stimulant effects and lack of safety data.

## Scientific Research

The provided research focuses exclusively on phytochemical composition and in vitro [antioxidant](/ingredients/condition/antioxidant) assessments rather than clinical trials or meta-analyses. No human clinical studies, RCTs, or PMIDs were included in the research dossier, indicating a significant gap in clinical evidence for mistletoe supplementation.

## Historical & Cultural Context

The research indicates that mistletoe has been used in conventional medicine and contains compounds historically associated with biological activity. However, specific traditional medicine systems, historical applications, and cultural contexts are not detailed in the provided sources.

## Synergistic Combinations

Quercetin, Green Tea Extract, Vitamin C, Echinacea, Astragalus

## Frequently Asked Questions

### What are the active compounds in mistletoe?

Mistletoe contains viscotoxins (small cytotoxic proteins), mistletoe lectins (ML-I, ML-II, ML-III), phenolic acids, flavonoids, and triterpenes. Viscotoxins and lectins are considered the primary bioactive compounds responsible for immune modulation and cellular effects.

### Is mistletoe safe to consume as a supplement?

Raw mistletoe berries and leaves are toxic and should never be consumed. Only standardized pharmaceutical extracts prepared under medical supervision are considered for therapeutic use. Most commercial mistletoe supplements lack proper standardization and safety data.

### How does mistletoe affect the immune system?

Mistletoe lectins bind to immune cell receptors and stimulate natural killer cell activity, increase cytokine production, and enhance macrophage function. Viscotoxins can induce programmed cell death in abnormal cells while potentially sparing healthy tissue.

### What types of mistletoe are used medicinally?

European mistletoe (Viscum album) is the primary species used medicinally, with different preparations made from mistletoe growing on specific host trees like apple, oak, or pine. The host tree may influence the concentration of active compounds in the final extract.

### Can mistletoe interact with cancer treatments?

Mistletoe may potentially interact with chemotherapy drugs and immunosuppressive medications used in cancer treatment. Some European oncologists use standardized mistletoe extracts as complementary therapy, but this requires careful medical supervision and coordination with primary treatments.

### What is the difference between European mistletoe (Viscum album) and other mistletoe species used in supplements?

European mistletoe (Viscum album) is the most extensively researched species in clinical trials and contains well-characterized viscotoxins and lectins that distinguish it from other mistletoe varieties. Other mistletoe species, such as those used in traditional Chinese or Ayurvedic medicine, have different phytochemical profiles and less robust clinical evidence. The European subspecies is standardized in pharmaceutical preparations, particularly in European oncology settings, making it the preferred choice for supplement formulations with documented safety and efficacy data.

### Who should avoid mistletoe supplements, and are there specific populations at higher risk?

Pregnant and nursing women should avoid mistletoe supplements due to insufficient safety data and potential uterotoxic effects from viscotoxins. Individuals with autoimmune conditions, immunosuppressive disorders, or those taking immunosuppressant medications should consult a healthcare provider, as mistletoe's immune-stimulating properties may exacerbate these conditions. Children and the elderly may require dose adjustments or closer monitoring due to limited pharmacokinetic studies in these populations.

### How does the preparation method of mistletoe (fermented vs. non-fermented extract) affect its potency?

Fermented mistletoe extracts, particularly those produced through specific bacterial fermentation processes, are believed to enhance the bioavailability and bioactivity of viscotoxins and viscolectins compared to standard dried or non-fermented preparations. European pharmaceutical standards, such as those used in mistletoe preparations marketed for complementary cancer care, often employ controlled fermentation to standardize active compound concentrations. However, direct comparative clinical evidence on fermented versus non-fermented forms in humans remains limited, making standardization and manufacturer documentation critical for product quality assessment.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*